Very important article what COVID "vaccines" really are

Gene therapy has not been tested enough

This is very important for everyone, including physicians to understand.

More good science thinking to justify NOT getting COVID shots.

Dr. Helene Banoun is an independent researcher, former research fellow at INSERM (French Institute for Health and Medical Research), Marseille, France. She has published several very important review papers during the crisis.

Dr. Banoun has recently published an analysis on the mRNA vaccines in consideration of definitions and regulations that apply to gene therapy. The title is: mRNA: Vaccine or Gene Therapy? The Safety Regulatory Issues.

For most people vaccinated, it was the first time they had been injected synthetic genetic code for a potentially lethal foreign protein (Wuhan Spike protein). A perfectly compliant American who started the COVID-19 vaccination program on time is on their seventh mRNA injection—an astonishing observation given the lack of any safety information concerning the cumulative effect of frequent, serial administrations.

Banoun makes the case that they should be classified as gene therapy products. There have been no counter arguments to the contrary.

Abstract

COVID-19 vaccines were developed and approved rapidly in response to the urgency created by the pandemic. No specific regulations existed at the time they were marketed. The regulatory agencies therefore adapted them as a matter of urgency. Now that the pandemic emergency has passed, it is time to consider the safety issues associated with this rapid approval. The mode of action of COVID-19 mRNA vaccines should classify them as gene therapy products (GTPs), but they have been excluded by regulatory agencies. Some of the tests they have undergone as vaccines have produced non-compliant results in terms of purity, quality and batch homogeneity. The wide and persistent biodistribution of mRNAs and their protein products, incompletely studied due to their classification as vaccines, raises safety issues. Post-marketing studies have shown that mRNA passes into breast milk and could have adverse effects on breast-fed babies. Long-term expression, integration into the genome, transmission to the germline, passage into sperm, embryo/fetal and perinatal toxicity, genotoxicity and tumorigenicity should be studied in light of the adverse events reported in pharmacovigilance databases. The potential horizontal transmission (i.e., shedding) should also have been assessed. In-depth vaccinovigilance should be carried out. We would expect these controls to be required for future mRNA vaccines developed outside the context of a pandemic.